Great Tree Pharmacy Co (ROCO:6469) EPS without NRI: NT$3.67 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6469 Great Tree Pharmacy Co Ltd ROCO:6469
70 GF Score
Price NT$78.60
GF Value NT$178.02
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Great Tree Pharmacy Co EPS without NRI?

Great Tree Pharmacy Co ROCO:6469 +0.64% 70 EPS without NRI is NT$3.67 as of Mar. 2026. GuruFocus rates ROCO:6469 with a GF Score™ of 70/100 and a GF Value™ of NT$178.02 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Great Tree Pharmacy Co ranks worse than 72.89% on this metric.

Great Tree Pharmacy Co's earnings per share without non-recurring items for the three months ended in Mar. 2026 was NT$0.82. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was NT$3.67.

During the past 12 months, Great Tree Pharmacy Co's average earnings per share (NRI) Growth Rate was -17.00% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -6.10% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 20.80% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 28.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Great Tree Pharmacy Co's EPS without NRI or its related term are showing as below:

ROCO:6469' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -6.1   Med: 15.35   Max: 70.1
Current: -6.1

During the past 13 years, Great Tree Pharmacy Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 70.10% per year. The lowest was -6.10% per year. And the median was 15.35% per year.

ROCO:6469's 3-Year EPS without NRI Growth Rate is ranked worse than
72.89% of 509 companies
in the Healthcare Providers & Services industry
Industry Median: 11.7 vs ROCO:6469: -6.10

Great Tree Pharmacy Co's EPS (Diluted) for the three months ended in Mar. 2026 was NT$0.82. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was NT$3.67.

Great Tree Pharmacy Co's EPS (Basic) for the three months ended in Mar. 2026 was NT$0.83. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was NT$3.77.


Great Tree Pharmacy Co  (ROCO:6469) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Great Tree Pharmacy Co EPS without NRI Related Terms


Great Tree Pharmacy Co EPS without NRI Historical Data

* Premium members only.

The historical data trend for Great Tree Pharmacy Co's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Great Tree Pharmacy Co EPS without NRI Chart

Great Tree Pharmacy Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.76 4.70 4.41 4.51 3.89

Great Tree Pharmacy Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.05 1.05 0.84 0.96 0.82

Great Tree Pharmacy Co EPS without NRI Competitor Comparison

For the Pharmaceutical Retailers subindustry, Great Tree Pharmacy Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Great Tree Pharmacy Co PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Great Tree Pharmacy Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Great Tree Pharmacy Co's PE Ratio without NRI falls into.


ROCO:6469
70GF Score
Great Tree Pharmacy Co Ltd ROCO:6469
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Great Tree Pharmacy Co EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$3.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of NT$3.67 mean?
Great Tree Pharmacy Co (ROCO:6469) has a EPS without NRI of NT$3.67 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Great Tree Pharmacy Co and its competitors. According to the industry distribution chart, Great Tree Pharmacy Co ranks #371 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 72.9%.
Is Great Tree Pharmacy Co's EPS without NRI too high?
Great Tree Pharmacy Co's current EPS without NRI is NT$3.67. Based on the distribution chart, Great Tree Pharmacy Co ranks #371 out of 509 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Great Tree Pharmacy Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Great Tree Pharmacy Co's EPS without NRI compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Great Tree Pharmacy Co ranks #371 out of 509 companies for EPS without NRI. This places Great Tree Pharmacy Co in the lower half of its industry. The industry median EPS without NRI is 11.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.70, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Great Tree Pharmacy Co and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Great Tree Pharmacy Co's current EPS without NRI is NT$3.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Great Tree Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Great Tree Pharmacy Co (ROCO:6469) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$178.02, compared to a current price of NT$78.60 — trading 55.8% below its estimated fair value. The current EPS without NRI is NT$3.67. Great Tree Pharmacy Co's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Great Tree Pharmacy Co (ROCO:6469), the current EPS without NRI is NT$3.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Great Tree Pharmacy Co (ROCO:6469) Overvalued in 2026?

Based on GuruFocus' analysis, Great Tree Pharmacy Co stock appears to be undervalued. The current stock price of NT$78.60 is trading 55.8% below its estimated GF Value™ of NT$178.02. GuruFocus considers Great Tree Pharmacy Co to be Significantly Undervalued.

Key valuation signals for ROCO:6469:

  • EPS without NRI: NT$3.67
  • GF Value™: NT$178.02 vs. price of NT$78.60 (55.8% below fair value)
  • GF Score™: 70/100 with 5 warning signs

No single metric tells the full story. See the ROCO:6469 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Great Tree Pharmacy Co Business Description

Address No.186, Fuxing Road, 18th Floor, Taoyuan District, Taoyuan, TWN, 330046
Great Tree Pharmacy Co Ltd engages in management and trading of various drugs, health supplements, maternity and infant products, and cosmetics products. It also provides coordinated medicine procurement services to various clinics, outpatient centers, and medical communities. Besides, it is also an agency for domestic and foreign health care products sold in clinics, outpatient centers, and medical communities. Its products include infant formula, baby diapers, Maternal and Infant Related, Adult drinks, Nutrition and health care, Body care, Daily Necessities, medical equipment, and Pet products.
70GF Score

Get the complete analysis for ROCO:6469

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$78.60
Price
NT$178.02
GF Value